Table 1.
An overview of major vaccine information [[3], [4], [5],7,[9], [10], [11], [12], [13], [14], [15], [16], [17]].
Vaccine | Type | Doses; days between doses | Price per dose USD | Published efficacy | Effectiveness vs variants | Additional information |
---|---|---|---|---|---|---|
Pfizer-BioNTech | mRNA | 2; 21 days | $19.50 | 95% [4] | Effective against Alpha, and Beta variants in real world; neutralizing antibodies identified for Delta, and Lambda variants [18] |
|
Moderna | mRNA | 2; 28 days | $32−37 | 95% [3] | Neutralizing antibodies identified against Alpha, Beta, Delta, Gamma, Eta, and Kappa variants [16] |
|
AstraZeneca-University of Oxford | Adenovirus-based | 2; 28−84 days | $2.15–$5.25 | 70% [5] | Neutralizing antibodies identified against Alpha, Beta, Gamma, Delta, and Kappa variants [5] |
|
Johnson & Johnson | Adenovirus-based | 1 | $10 | 64−72% [7] | Neutralizing antibodies identified against Alpha, Beta, Delta, Gamma, Epsilon, and Kappa variants [19] |
|
Russia’s Sputnik V Vaccine | Adenovirus-based | 2; 21 days | $10 | 91.60% [9] | Limited efficacy results published |
|
Sinovac Biotech | Inactivated SARS-CoV-2 virus | 2; 28 days | $29.75 | 50.38–91.25% [10] | Limited efficacy results published |
|
Novavax | Protein-based vaccine | 2; 21 days | $16 | 89.70% [17] | Effective against Alpha and Beta variants [17] |
|